Taken together, these results indicate that GPF mitigates AD-like pathology and behavioral deficits in C. elegans models by enhancing mitophagy, reducing Aβ and tau toxicity, and alleviating oxidative stress. The gene discussed is MAPT; the disease is Alzheimer disease.